Mersana Therapeutics Secures $27,000,000 Series A Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a0656892-be26-469b-869e-73cea03bf5a9&Preview=1 -
Date
7/31/2012 -
Company Name
Mersana Therapeutics -
Mailing Address
840 Memorial Drive Cambridge, MA 02139 -
Company Description
Mersana Therapeutics, Inc. (formerly Nanopharma Corp.) is focused on developing novel oncology agents based on Fleximer, a stealth material that enhances the pharmacokinetics and safety of drugs. -
Website
http://www.mersana.com -
Transaction Type
Venture Equity -
Transaction Amount
$27,000,000 -
Transaction Round
Series A -
Proceeds Purposes
The proceeds from this financing will be used to advance Mersana’s Fleximer-based ADC technology and to generate a pipeline of proprietary next-generation ADCs. -
M&A Terms
-
Venture Investor
New Enterprise Associates -
Venture Investor
Pfizer Venture Investments -
Venture Investor
Fidelity BioSciences -
Venture Investor
ProQuest Investments -
Venture Investor
Rho Ventures -
Venture Investor
Harris & Harris Group
